Sign Up to like & get
recommendations!
0
Published in 2017 at "Clinical therapeutics"
DOI: 10.1016/j.clinthera.2016.12.005
Abstract: PURPOSE Although vancomycin has been the mainstay of therapy for methicillin-resistant Staphylococcus aureus (MRSA) infections, its effectiveness has been challenged. Combination therapy may be used for patients with persistent MRSA bacteremia refractory to initial therapy.…
read more here.
Keywords:
combination;
bacteremia;
combination therapy;
vancomycin ceftaroline ... See more keywords